Specialist neurological health centre set to redefine treatment outcomes and personalised, patient-centred care for UAE health sector
Abu Dhabi, UAE, 28 November 2024: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a subsidiary of PureHealth, today announced the opening of its Neuroscience Institute. Dedicated to providing world-class, comprehensive care for neurological conditions, the new centre will cater to patients of all ages, focusing on the latest technologies and breakthrough treatments in neuroscience.
Committed to advancing the diagnosis, treatment and research of neurological conditions, the institute operates across various divisions including adult neurology, paediatric neurology, neurosurgery and interventional neuroradiology. SSMC is eager to uphold the highest standards of excellence in innovation and enhance patient outcomes by integrating cutting-edge research with the implementation and adoption of advanced diagnostic and therapeutic technologies.
Reinforcing its mission to provide a patient-centric approach across all its operations, the launch of SSMC’s new institute is another clear addition to a growing series of specialised care services – all driven by an ethos based on seamlessly integrated compassionate care.
The Neuroscience Institute will offer accessible, innovative services locally that were previously only available internationally.
Commenting on the launch of the new institute, Dr. Marwan Al Kaabi, chief executive officer at SSMC, said: “As part of our ongoing commitment to bringing life-changing advancements and elevating the standard of care through breakthrough innovations, our Neuroscience Institute will serve as a centre of comprehensive neurological care for patients in the UAE and beyond.
“By providing advanced patient-centric services, we are creating a leading institute that will not only serve patients from the region but will contribute to finding solutions to unmet patients’ needs on a global level.”
Looking to the future, the Neuroscience Institute will also prioritise patient education, emphasising early diagnosis and prevention of neurological disorders in both adults and children. By actively engaging with the community, SSMC seeks to raise awareness of neurological conditions, empowering patients with knowledge and equipping them with the resources to explore the latest care options through comprehensive education programmes.
To further advance its mission, the institute plans to establish collaborations with academic institutions to enhance research and training initiatives. It will also forge partnerships with industry leaders to integrate the latest medical technologies into its application of neurology, neurosurgery and interventional neuroradiology treatment.
Dr. Abdulqader Almessabi, acting chief medical officer at SSMC, added: “A key strength of the Neuroscience Institute is its comprehensive care approach, which facilitates coordinated care pathways for all patients.
“Featuring a highly skilled team of adult and paediatric neurologists, neurosurgeons and interventional neuroradiologists, our aim at SSMC is to offer access to a full spectrum of services and specialised care across every discipline of neuroscience. From diagnosis and surgery to interventional procedures and rehabilitation, the institute is dedicated to leveraging groundbreaking technologies and novel treatment methods to elevate the quality of life for patients – regardless of age or condition.”
